MT-477

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMT-477
Drug Alias Nameprotein kinase C inhibitor/Ras GTPase inhibitor (Medisyn Technologies)MT-477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras inhibitorsProtein kinase C inhibitors
TargetsProtein kinase CGTPase Ras
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedisyn Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedisyn Technologies Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A